Utilisation de nanoparticules comme agent radiosensibilisant en radiothérapie : où en est-on ?

Caster, 2017, Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials, Nanomed Nanobiotechnol, 9, 1, 10.1002/wnan.1416 Maeda, 2000, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J Control Release, 65, 271, 10.1016/S0168-3659(99)00248-5 Verry, 2016, MRI-guided clinical 6-MV radiosensitization of glioma using a unique gadolinium-based nanoparticles injection, Nanomedicine (Lond), 11, 2405, 10.2217/nnm-2016-0203 Rima, 2013, Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles, Biomaterials, 34, 181, 10.1016/j.biomaterials.2012.09.029 Stefancikova, 2014, Cell localisation of gadolinium-based nanoparticles and related radiosensitising efficacy in glioblastoma cells, Cancer Nanotechnol, 5, 6, 10.1186/s12645-014-0006-6 Porcel, 2012, Nano-Sensitization under gamma rays and fast ion radiation, J Phys, 373 Wozny, 2017, Gadolinium-based nanoparticles as sensitizing agents to carbon ions in head and neck tumor cells, Nanomedicine, 13, 2655, 10.1016/j.nano.2017.07.015 Lacombe, 2017, Particle therapy and nanomedicine: state of art and research perspectives, Cancer Nanotechnol, 8, 9, 10.1186/s12645-017-0029-x McMahon, 2011, Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles, Sci Rep, 1, 18, 10.1038/srep00018 Delorme, 2017, Comparison of gadolinium nanoparticles and molecular contrast agents for radiation therapy-enhancement, Med Phys, 44, 5949, 10.1002/mp.12570 Porcel, 2010, Platinum nanoparticles: a promising material for future cancer therapy?, Nanotechnology, 21, 85103, 10.1088/0957-4484/21/8/085103 Tubiana, 1986 Rancoule, 2016, Nanoparticles in radiation oncology: from bench-side to bedside, Cancer Lett, 375, 256, 10.1016/j.canlet.2016.03.011 Pan, 2009, Goldnanoparticles of diameter 1.4nm trigger necrosis by oxidative stress and mitochondrial damage, Small, 5, 2067, 10.1002/smll.200900466 Mateo, 2014, Oxidative stress contributes to gold nanoparticle induced cytotoxicity in human tumor cells, Toxicol Mech Methods, 24, 161, 10.3109/15376516.2013.869783 Miladi, 2015, Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma, Nanomedicine, 11, 247, 10.1016/j.nano.2014.06.013 Taggart, 2014, The role of mitochondrial function in gold nanoparticle mediated radiosensitisation, Cancer Nanotechnol, 5, 5, 10.1186/s12645-014-0005-7 Ghita, 2017, A mechanistic study of gold nanoparticle radiosensitisation using targeted microbeam irradiation, Sci Rep, 7, 44752, 10.1038/srep44752 Abbott, 1999, Mitogen-activated protein kinase kinase 2 activation is essential for progression through the G2/M checkpoint arrest in cells exposed to ionizing radiation, J Biol Chem, 274, 2732, 10.1074/jbc.274.5.2732 Yao, 2015, Chemical radiosensitivity of DNA induced by gold nanoparticles, J Biomed Nanotechnol, 11, 478, 10.1166/jbn.2015.1922 Mahmoudi, 2011, Effect of Nanoparticles on the cell life cycle, Chem Rev, 111, 3407, 10.1021/cr1003166 Roa, 2009, Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle, Nanotechnology, 20, 375101, 10.1088/0957-4484/20/37/375101 Tsai, 2011, Identification of the nanogold particle-induced endoplasmic reticulum stress by omic techniques and systems biology analysis, ACS Nano, 5, 9354, 10.1021/nn2027775 Arora, 2012, Nanotoxicology and in vitro studies: the need of the hour, Toxicol Appl Pharmacol, 258, 151, 10.1016/j.taap.2011.11.010 2011 Hainfeld, 2004, The use of gold nanoparticles to enhance radiotherapy in mice, Phys Med Biol, 49, N309, 10.1088/0031-9155/49/18/N03 Her, 2017, Gold nanoparticles for applications in cancer radiotherapy: mechanisms and recent advancements, Adv Drug Deliver Rev, 109, 84, 10.1016/j.addr.2015.12.012 Gad, 2012, Evaluation of the toxicity of intraveinous delivery of Auroshell particles, Int J Toxicol, 31, 584, 10.1177/1091581812465969 Bonvalot, 2017, First-in-Human study testing a new radio enhancer using nanoparticles (NBTXR3) activated by radiation therapy in patients with locally advanced soft tissue sarcomas, Clin Cancer Res, 23, 908, 10.1158/1078-0432.CCR-16-1297 Bonvalot, 2019, NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial, Lancet Oncol, 20, 1148, 10.1016/S1470-2045(19)30326-2 2019 Lux, 2018, AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine, Br J Radiol, 91, 20180365, 10.1259/bjr.20180365 Verry, 2019, Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a phase I study protocol, BMJ Open, 9, e023591, 10.1136/bmjopen-2018-023591